-
Product Insights
Topa Mine
The Topa Mine is a coal mine in India. It is currently in operation. Empower your strategies with our Topa Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
NewIncontinence Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Incontinence Devices Pipeline Market Report Overview Incontinence devices are externally, or internally worn devices intended to protect the skin from the involuntary loss of urine. The Incontinence Devices pipeline market research report provides extensive coverage of the Incontinence Devices under development. It reviews details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Additionally, it reviews major players involved in the pipeline product development....
-
Product Insights
NewPemphigus Vulgaris – Drugs In Development, 2024
Empower your strategies with our Pemphigus Vulgaris – Drugs In Development, 2024 report and make more profitable business decisions. Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on the skin and the mucous membranes. Risk factors include race, gender, and age. Symptoms of pemphigus vulgaris include painful blisters that start in the mouth, and skin blisters that come and go. The blisters always occur near the surface of the skin and there is oozing, crusting, or peeling at...
-
Product Insights
NewPemphigus – Drugs In Development, 2024
Empower your strategies with our Pemphigus – Drugs In Development, 2024 report and make more profitable business decisions. Pemphigus is is an autoimmune disease that causes blistering of the skin and the the mucous membranes inside of the mouth, nose, throat, eyes, and genitals. It is characterized by loss of normal cell-cell adhesion (acantholysis) and by the presence of pathogenic (predominantly IgG) autoantibodies reacting against epithelial adhesion molecules called desmogleins, proteins that bind skin cells to one another. When these bonds...
-
Product Insights
NewCeliac Disease – Drugs In Development, 2024
Empower your strategies with our Celiac Disease – Drugs In Development, 2024 report and make more profitable business decisions. Celiac disease is an autoimmune disorder caused by an immune response to wheat protein gluten. Symptoms include weight loss, vomiting, abdominal bloating, abdominal pain, and persistent diarrhea. Risk factors include lupus, rheumatoid arthritis, type 1 diabetes, autoimmune liver disease, Sjogren’s syndrome, and Turner syndrome. Treatment includes steroids such as betamethasone and prednisolone. Treatment also involves adhering to strict gluten-free diet. The Celiac...
-
Product Insights
NewCholangitis – Drugs In Development, 2024
Empower your strategies with our Cholangitis – Drugs In Development, 2024 report and make more profitable business decisions. Cholangitis refers to inflammation of the bile ducts, which are tubes that carry bile from the liver to the gallbladder and small intestine. This condition can be acute or chronic and is often caused by a bacterial infection or blockage of the bile ducts. Cholangitis can cause a range of symptoms, which may include abdominal pain, particularly in the upper right side; jaundice...
-
Product Insights
NewUveitis – Drugs In Development, 2024
Empower your strategies with our Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. The predisposing factors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPM-203 in Pemphigus Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPM-203 in Pemphigus Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TPM-203 in Pemphigus Vulgaris Drug Details: TPM203 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LTP-001 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTP-001 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LTP-001 in Idiopathic Pulmonary Fibrosis Drug Details: LTP-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPM-502 in Celiac Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TPM-502 in Celiac DiseaseDrug Details:TPM-502 is under development for the treatment of celiac disease. The therapeutic...